Wolfspeed Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Wolfspeed Inc trades at $32.5 (market cap $1.53B), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Wolfspeed Inc nearer its low. Which is the better fit depends on your goals.
| WOLF | XBI | |
|---|---|---|
Market Cap | $1.53B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $73.68 | $164.28 |
52-Week Low | $1.19 | $85.16 |
Enterprise Value | $2.19B | — |
Trailing returns across standard periods
Latest headlines on both assets
Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →